Reading this clinical breakthrough? See how real patients are applying these numbers in real life. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
★ Breakthrough Medical Research • 15 Landmark Multi-Trial Guides • 6,280 Indexed Studies

Randomized Controlled Human Trials (RCTs) (1,760 Indexed Studies)

Prospective randomized human trials, crossover pharmacokinetic studies, and ClinicalTrials.gov interventional readouts with direct participant sample sizes (N). Every study summary reports the trial design, participant sample size (N), primary outcome highlight, and direct link to the formal NCBI PubMed or federal record.

★ #1 Lead Breakthrough Study • NEJM SURMOUNT-1 (176 Weeks) N = 1,032 Adults • p < 0.001

Once-Weekly Tirzepatide Cuts Type 2 Diabetes Progression by 94% Over 3 Years—With a 22.9% Sustained Weight Reduction

The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).

Two biomedical scientists in white lab coats inside a sunlit medical research laboratory pipetting clinical assay samples and reviewing trial results
Inside the Clinical Evidence Lab: Our research desk audits 6,280 human trials from NEJM, The Lancet, JAMA, and NCBI PubMed—reporting true Absolute Risk Reduction (ARR) and sample sizes (N) without pharma spin.
3. All Indexed Clinical Studies (1,760)

Randomized Controlled Human Trials (RCTs) (1,760)

Page 11 of 59 • Sorted by Participant Sample Size (N)
Randomized Controlled Trial PMID 42970292

Cost-Effectiveness of Remote Symptom Monitoring During Adjuvant Endocrine Therapy in Breast Cancer

Of 304 participants randomized, 214 had complete data. The mean (SD) age was 58.9 (10.8) years. Mean (SD) total costs were highest for the EUC arm ($11 596.10 [$30 231.95]) compared with the app arm ($6682.15 [$12 963.34]; difference, -$4913.95 [95% CI, -$12 864.27 to $3036.37]) and app plus feedback arm ($11 407.85 [$47 068.42]; differen.

JAMA network open • 2026-11-02 Read Study
Randomized Controlled Trial PMID 42975217

A Comparative Study of the Efficacy and Safety of Two Misoprostol Regimens for Labour Induction at Term in Delta State: A Two-centre Triple-blind Randomised Controlled Trial

This study demonstrated comparable efficacy between hourly titrated oral misoprostol and four-hourly VM for labour induction. However, hourly titrated oral misoprostol exhibited a more favourable safety profile, as regards abnormal uterine contractions, foetal heart rate patterns and caesarean section rate.

The Nigerian postgraduate medical journal • 2026-11-01 Read Study
Randomized Controlled Trial PMID 42960904

Long-Term Marginal Bone Stability of BOPT Restorations on Bone-Level vs. Tissue-Level Implants: An 8-Year Prospective Clinical Study

Tissue-level implants showed lower mesial marginal bone loss after eight years, whereas distal and mean marginal bone loss did not differ significantly between systems. These findings should be interpreted considering the differences between the implant systems and the limitations of two-dimensional radiographic assessment.

Medicina oral, patologia oral y cirugia bucal • 2026-11-01 Read Study
Randomized Controlled Trial PMID 42966369

Supervised physiotherapeutic scoliosis-specific exercises provide limited additional benefit at 24 months in braced adolescents with idiopathic scoliosis

Supervised PSSE provided a statistically significant but clinically modest radiological benefit over self-directed exercise. This did not translate into a higher likelihood of clinically meaningful radiological improvement. No sustained clinically meaningful quality-of-life benefit was shown.

The bone & joint journal • 2026-11-01 Read Study
Randomized Controlled Trial PMID 42969981

Comparison of the opioid-sparing effects of a combination of dexamethasone, paracetamol, and ketorolac versus paracetamol and ketorolac in patients undergoing total laparoscopic hysterectomy: A prospective double-blind randomized controlled trial

In patients undergoing TLH, a combination of dexamethasone, PCM, and ketorolac reduced 24-h opioid use, improved pain scores, and minimized immediate postoperative nausea and vomiting.

Indian journal of pharmacology • 2026-11-01 Read Study
Randomized Controlled Trial PMID 42975003

Randomized Controlled Trial: Enhancing Empathic Functioning in Married Individuals Experiencing Marital Conflict Through Mentalization-Based Therapy in Iran

After controlling for pretest empathy, the experimental group showed significantly higher posttest empathy than the control group, F(1, 27) = 12.643, p = 0.001, partial η 2 = 0.319. The findings provide preliminary evidence that participation in MBT may be associated with improved self-reported empathy in this population.

Journal of marital and family therapy • 2026-10-24 Read Study
Randomized Controlled Trial PMID 42967331

Randomized Controlled Trial: Effects of Dual-Task Training With and Without Backward Walking on Balance, Functional Mobility, and Participation in Ambulatory Children With Spastic Diplegic Cerebral Palsy

In ambulatory children with spastic diplegic CP (GMFCS Levels I-II), adding BW to DTT was associated with a small additional improvement in functional mobility over 4 weeks (approximately 1 s on the TUG) of uncertain clinical importance, whereas superiority for balance or participation was not demonstrated; the trial was not powered for t.

Physiotherapy research international : the journal for researchers and clinicians in physical therapy • 2026-10-24 Read Study
Randomized Controlled Trial PMID 42967746

Randomized Controlled Trial: Phytosterol-enriched corn and wheat germ blended oil improves lipid metabolism in hyperlipidemia via the AMPK/PPARα/CPT1 pathway

PCWGO effectively improved lipid metabolism in both humans and animal models and may have beneficial effects on oxidative status. Its hypolipidemic effects may be related to activation of the AMPK/PPARα/CPT1 pathway, promoting fatty acid β-oxidation.

Food research international (Ottawa, Ont.) • 2026-10-24 Read Study
Evidence Methodology, PubMed Verification & YMYL Standards

Frequently Asked Questions About dotMD Clinical Trial Breakdowns

Why does dotMD report both Absolute Risk Reduction (ARR) and Relative Risk Reduction (RRR) on clinical trials?

Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.

How does dotMD separate human randomized controlled trials (RCTs) from animal or observational studies?

Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.

Why did dotMD replace synthetic "Study Rigor Scores" with primary PubMed PMIDs and trial metadata?

Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.

How do dotMD Research Breakdowns connect to Conditions, Medications, Supplements, and Specialist Doctors?

Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.